4-Aminopyridine
规格
504-24-5CAS 号
207-987-9EC 号
pyridin-4-amineIUPAC 名称
C5H6N2化学式
94.11 g/mol分子量
4-aminopyridine; 504-24-5; pyridin-4-amine; 4-Pyridinamine; Fampridine; Dalfampridine; 4-Pyridylamine; Avitrol; p-Aminopyridine; Ampyra; gamma-Aminopyridine; Amino-4 pyridine; Avitrol 200; FAMPYRA; Phillips 1861; Neurelan; 4 Aminopyridine; Fampridine-SR; fampridina; VMI 10-3; EL-970; DTXSID0023870; Mi-W-3; fampridinum; NSC-15041; VMI 103; BH3B64OKL9; 1,4-dihydropyridin-4-imine; N07XX07; Fampridine (4-aminopyridine); DTXCID003870; CHEBI:34385; 5-22-09-00106 (Beilstein Handbook Reference); NSC15041; Pymadine; Fampridine SR; VMI103; 4 Aminopyridine Sustained Release; Sustained Release, 4-Aminopyridine; Ampyra Extended Release; RefChem:54927; 207-987-9; 4-AP; Pyridine, 4-amino-; Pimadin (free base); Compound 1861; Amaya; Prc 1237; pyridin-4-ylamine; NSC 15041; Fampridine [INN]; .gamma.-Aminopyridine; Dalfampridine [USAN]; MFCD00006439; MLS000069400; CHEMBL284348; Dalfampridine (USAN); NCGC00015009-08; SMR000058211; ACETYL-2-13C CHLORIDE,2,2-DICHLORO- (9CI); Caswell No. 038; VMI-103; 4-amino pyridine; 4-amino-pyridine; 4- Aminopyridine; CAS-504-24-5; Ampyra (TN); HSDB 6037; SR-01000075299; EINECS 207-987-9; RCRA waste no. P008; UNII-BH3B64OKL9; EPA Pesticide Chemical Code 069201; Dalfampridine [USAN:INN]; BRN 0105782; Frampridine; Ampydin; BIIB041; Pymadin; AI3-52547; BIIB 041; Fampridine-PR; Dalfampridine (4-aminopyridine); Dalfampridine-ER; 4-pyridyl amine; para-aminopyridine; pyridine-4-amine; 3rxf; Neurelan (TN); pyridine-4-ylamine; 4AP; VMI-10-3; Fampyra (TN); pyridin-4-yl-amine; 4-Aminopyridine 10; Philips 1861; 4-AMINOPYRDINE; Spectrum_000155; Tocris-0940; Fampridine (JAN/INN); 4-Aminopyridine, 98%; FAMPRIDINE [JAN]; PYRIDINE,4-AMINO; Opera_ID_1768; Spectrum2_001413; Spectrum3_000914; Spectrum4_001013; Spectrum5_001501; Lopac-A-0152; DALFAMPRIDINE [II]; DALFAMPRIDINE [MI]; FAMPRIDINE [VANDF]; UPCMLD-DP125; WLN: T6NJ DZ; 4-Aminopyridine (4-AP); FAMPRIDINE [MART.]; 4-Aminopyridine, >=99%; DALFAMPRIDINE [HSDB]; FAMPRIDINE [WHO-DD]; Lopac0_000032; SCHEMBL53483; BSPBio_001562; DALFAMPRIDINE [VANDF]; KBioGR_000282; KBioGR_001505; KBioSS_000282; KBioSS_000635; 29212-32-6; DivK1c_000572; FAMPRIDINE [EMA EPAR]; SCHEMBL245056; SCHEMBL291100; SCHEMBL332270; SCHEMBL332451; SPECTRUM1501130; SPBio_001486; DALFAMPRIDINE [USP-RS]; 4 AP; BIIB-041; GTPL2416; orb1941039; orb2893743; orb3026006; Pyridin-4-Amine; Dalfampridine; SCHEMBL1397445; SCHEMBL1683855; SCHEMBL3865305; CL-COB-III-274-1; UPCMLD-DP125:001; BDBM10458; HMS501M14; KBio1_000572; KBio2_000282; KBio2_000635; KBio2_002850; KBio2_003203; KBio2_005418; KBio2_005771; KBio3_000563; KBio3_000564; KBio3_001888; NINDS_000572; Bio1_000353; Bio1_000842; Bio1_001331; Bio2_000282; Bio2_000762; HMS1361O04; HMS1791O04; HMS1921H15; HMS1989O04; HMS2092F05; HMS2234N24; HMS3260G05; HMS3267E21; HMS3370J03; HMS3402O04; HMS3414H15; HMS3678H13; HMS3886I09; KUC111877N; Pharmakon1600-01501130; DALFAMPRIDINE [ORANGE BOOK]; HY-B0604; Tox21_110065; Tox21_200793; Tox21_500032; CCG-39031; DALFAMPRIDINE [USP MONOGRAPH]; EBC-03934; HB1073; NSC757845; RB8003; s5028; SBB004393; STK298717; AKOS000119896; Tox21_110065_1; BS-3729; DB06637; FA00151; LP00032; MSK000551-100M; NSC-757845; SDCCGMLS-0066228.P001; SDCCGSBI-0050021.P004; IDI1_000572; IDI1_034032; p-Aminopyridine [UN2671] [Poison]; MSK000551-1000M; NCGC00015009-01; NCGC00015009-02; NCGC00015009-03; NCGC00015009-04; NCGC00015009-05; NCGC00015009-06; NCGC00015009-07; NCGC00015009-09; NCGC00015009-10; NCGC00015009-11; NCGC00015009-12; NCGC00015009-13; NCGC00015009-14; NCGC00015009-16; NCGC00015009-23; NCGC00015009-24; NCGC00015009-25; NCGC00024890-01; NCGC00024890-02; NCGC00024890-03; NCGC00024890-04; NCGC00024890-05; NCGC00024890-06; NCGC00024890-07; NCGC00024890-08; NCGC00024890-09; NCGC00024890-10; NCGC00258347-01; NCGC00260717-01; BP-21343; SBI-0050021.P003; DB-028705; A0414; EU-0100032; NS00002207; ST45053817; EN300-21310; FAMPRIDINE (4-AMINOPYRIDINE) [VANDF]; A 0152; D04127; 4-Aminopyridine Solution in Methanol, 100ug/mL; AB00052209_12; [J.Pharmacol.Exp.Ther. 275:864 (1995)]; 4-Aminopyridine Solution in Methanol, 1000ug/mL; AC-907/25014071; F047207; Q372539; 4-Aminopyridine, PESTANAL(R), analytical standard; SR-01000075299-1; SR-01000075299-3; SR-01000075299-5; BRD-K22482860-001-20-6; BRD-K22482860-001-21-4; F2190-0487; Z104495272; Dalfampridine, United States Pharmacopeia (USP) Reference Standard; InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7同义词
含有4-Aminopyridine的产品
삼오팜프리딘서방정10밀리그램(팜프리딘)FAMPRIDINA STADA 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGFAMPRIDINA QUALIGEN 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGFAMPRIDINA AUROVITAS 10 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGFAMPRIDINA ACCORD 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGFAMPYRA 10 MG COMPRIMIDOS DE LIBERACION PROLONGADAFAMPYRA 10 MG COMPRIMIDOS DE LIBERACION PROLONGADAFAMPYRA 10 mg, comprimé à libération prolongéeFAMPRIDINE ZENTIVA LP 10 mg, comprimé à libération prolongéeFAMPRIDINE VIATRIS LP 10 mg, comprimé à libération prolongéeFAMPRIDINE TEVA LP 10 mg, comprimé à libération prolongéeFAMPRIDINE EG LP 10 mg, comprimé à libération prolongée
第 1/2 页
销售4-Aminopyridine的公司
HD
Hangzhou Dingyan Chem Co., LtdChinaDC
DAYANG CHEM (HANGZHOU) CO.,LTDChinaHR
Hengshui Rayson Chemical Technology Co. , Ltd.ChinaVS
VIATRIS SANTEFranceTS
TEVA SANTEFrance第 1/2 页